Founded in June 2011, their focus is on neurogastroenterology as well as minimally invasive early stage cancer diagnosis. They have just launched Cellvizio, an early stage cancer detection probe, which does away with the need for a traditional biopsy
Cellvizio is a probe that enables detection of cancer at an early stage. By selling a product like Cellvizio to both private and government hospitals, research institutions have helped generate revenues for the company. A wider product portfolio and a stronger distribution network is what the Invive team is now working on.
http://www.moneycontrol.com/news/special-videos/invive-healthcare-introducing-innovative-medical-tech-_704140.html
No comments:
Post a Comment